ATE223729T1 - Verwendung von igf-i oder entsprechenden analogen in der vorbeugung von diabetes - Google Patents

Verwendung von igf-i oder entsprechenden analogen in der vorbeugung von diabetes

Info

Publication number
ATE223729T1
ATE223729T1 AT95925202T AT95925202T ATE223729T1 AT E223729 T1 ATE223729 T1 AT E223729T1 AT 95925202 T AT95925202 T AT 95925202T AT 95925202 T AT95925202 T AT 95925202T AT E223729 T1 ATE223729 T1 AT E223729T1
Authority
AT
Austria
Prior art keywords
diabetes
igf
prevention
subject
high risk
Prior art date
Application number
AT95925202T
Other languages
English (en)
Inventor
Charles Thivolet
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE223729T1 publication Critical patent/ATE223729T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95925202T 1994-07-04 1995-06-22 Verwendung von igf-i oder entsprechenden analogen in der vorbeugung von diabetes ATE223729T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402370A SE9402370D0 (sv) 1994-07-04 1994-07-04 Use of IGF-I
PCT/SE1995/000776 WO1996001124A1 (en) 1994-07-04 1995-06-22 Use of igf-i or analogues thereof in the prevention of diabetes

Publications (1)

Publication Number Publication Date
ATE223729T1 true ATE223729T1 (de) 2002-09-15

Family

ID=20394633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95925202T ATE223729T1 (de) 1994-07-04 1995-06-22 Verwendung von igf-i oder entsprechenden analogen in der vorbeugung von diabetes

Country Status (10)

Country Link
US (2) US6342227B1 (de)
EP (1) EP0759776B1 (de)
JP (1) JPH10502367A (de)
AT (1) ATE223729T1 (de)
AU (1) AU689922B2 (de)
CA (1) CA2194403A1 (de)
DE (1) DE69528168T2 (de)
IL (1) IL114343A0 (de)
SE (1) SE9402370D0 (de)
WO (1) WO1996001124A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402331D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab New use
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
CA2369451C (en) 1999-04-08 2009-09-22 Genentech, Inc. Composition based on oppositely-charged polypeptides
EP1282437B1 (de) 2000-05-16 2008-03-19 Genentech, Inc. Behandlung von knorpelerkrankungen
HUP0500733A3 (en) 2001-02-09 2010-01-28 Genentech Inc Crystallization of igf-1
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
WO2011004051A1 (es) 2009-07-10 2011-01-13 Universidad Autónoma De Barcelona Composiciones de terapia génica para prevenir y/o tratar enfermedades autoinmunes
US10799564B1 (en) * 2019-05-06 2020-10-13 Baxter International Inc. Insulin premix formulation and product, methods of preparing same, and methods of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0561137B1 (de) 1983-04-25 2002-07-03 Chiron Corporation Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren
US4963665A (en) 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
SE8703625D0 (sv) 1987-09-18 1987-09-18 Kabivitrum Ab New medical use
US4988675A (en) 1988-02-05 1991-01-29 Ciba-Geigy Corporation Method for preventing secondary effects
GB8920381D0 (en) 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
SE9201573D0 (sv) * 1992-05-19 1992-05-19 Kabi Pharmacia Ab Use of igf-1

Also Published As

Publication number Publication date
AU689922B2 (en) 1998-04-09
JPH10502367A (ja) 1998-03-03
EP0759776A1 (de) 1997-03-05
IL114343A0 (en) 1995-10-31
WO1996001124A1 (en) 1996-01-18
DE69528168D1 (de) 2002-10-17
DE69528168T2 (de) 2003-01-09
CA2194403A1 (en) 1996-01-18
AU2940795A (en) 1996-01-25
US20020132772A1 (en) 2002-09-19
SE9402370D0 (sv) 1994-07-04
US6342227B1 (en) 2002-01-29
EP0759776B1 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
ATE223729T1 (de) Verwendung von igf-i oder entsprechenden analogen in der vorbeugung von diabetes
DE3566314D1 (en) Apparatus for saving a calculator status
BR6300196U (pt) Tenis, em especial chuteira, com uma primeira sola elastica
JPS5388761A (en) Electronic watch with auxiliary battery
NO863209L (no) Fremgangsmaate for fremstilling av en elektrode og dens bruk i elektrokjemiske prosesser.
IT8348747A0 (it) Derivati amminometil-benzenici eteroaril-sostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni farmaceutiche che li contengono
ATE65696T1 (de) Verwendung von defibrotid bei der behandlung von zustaenden akuter nierenschwaeche.
ATE207758T1 (de) Verwendung von igf-1
AU548677B2 (en) Peptides derived from glucagon
IT1141184B (it) Elettrodo attivo,cella elettrochimica comprendente detto elettrodo e metodo di fabbricazione dell'elettrodo
IT8419668A0 (it) Componente elettronico integrato di tipo "single-in-line" eprocedimento per la sua fabbricazione.
IT8419681A0 (it) Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
DK468885A (da) Middel til topisk behandling af betaendelsestilstande i huden
Woolfe Counselling in a world of crisis: towards a sociology of counselling.
DE68903652D1 (de) Schraubfilter mit kannelliertem oder analogem gehaeuse.
JPS522465A (en) Solar battery wrist watch
JPS6474401A (en) Disk type thickness gauge
JPS5257731A (en) Light source for information reading element
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
Williams Public Processes and Public Involvement in Wetland Regulatory Programs
JPS5429597A (en) Diapason type crystal oscillator
JPS5437645A (en) Computer system
JPS5319069A (en) Electronic digital timepiece with perpetual calendar
Leslie Political platform of the computer.
Hagen Tim Hagen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties